Prelude Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,000
| Closed | -$232K | – | 2619 |
|
|
2021
Q3 | $232K | Buy |
38,000
+1,700
| +5% | +$10.6K | 0.01% | 1280 |
|
|
2021
Q2 | $299K | Buy |
36,300
+100
| +0.3% | +$850 | 0.02% | 1194 |
|
|
2021
Q1 | $324K | Buy |
36,200
+5,200
| +17% | +$59.6K | 0.02% | 1106 |
|
|
2020
Q4 | $358K | Buy |
31,000
+3,600
| +13% | +$41.8K | 0.03% | 845 |
|
|
2020
Q3 | $285K | Sell |
27,400
-600
| -2% | -$7.35K | 0.04% | 578 |
|
|
2020
Q2 | $368K | Buy |
28,000
+25,500
| +1,020% | +$264K | 0.06% | 563 |
|
|
2020
Q1 | $20K | Buy |
+2,500
| New | +$37.7K | ﹤0.01% | 995 |
|
|
2019
Q3 | – | Sell |
-551
| Closed | -$7K | – | 2399 |
|
|
2019
Q2 | $7K | Buy |
+551
| New | +$6.36K | ﹤0.01% | 1478 |
|
|
2019
Q1 | – | Sell |
-524
| Closed | -$6K | – | 2462 |
|
|
2018
Q4 | $6K | Buy |
+524
| New | +$8.22K | ﹤0.01% | 1594 |
|